Himalaya Drug Company eyes doubling sales to Rs 4,000 cr by FY20 savita thakur thakur21 Dec 2015 1:41 PM ISTNew Delhi: Herbal wellness major Himalaya Drug Company is looking to double its sales turnover to Rs 4,000 crore in the next four years as it sharpens...
FDA delays BioMarin drug approval, gives investors hope savita thakur thakur20 Dec 2015 11:44 AM ISTBy Vidya L NathanThe U.S. Food and Drug Administration pushed back its deadline to decide on drug developer BioMarin Pharmaceutical Inc's lead drug,...
GlaxoSmithKline gets lift from successful arthritis drug trials savita thakur thakur18 Dec 2015 12:07 PM ISTLondon: GlaxoSmithKline reported positive results from three pivotal studies of its experimental rheumatoid arthritis drug sirukumab, putting the...
Sharon receives EIR report from USFDA on inspection closure savita thakur thakur13 Dec 2015 2:52 PM ISTNew Delh: Drug firm Sharon Bio-Medicine said it has received the establishment inspection report (EIR) from the USFDA on closure of inspection of its...
AstraZeneca in talks to buy cancer drugmaker Acerta for $5 billion: WSJ savita thakur thakur12 Dec 2015 11:14 AM ISTBritish drugmaker AstraZeneca Plc is in advanced talks to buy privately held cancer drug developer Acerta Pharma BV for more than $5 billion (3.3...
Alembic Pharma arm ties up with Novartis for drug development savita thakur thakur11 Dec 2015 11:40 AM ISTNew Delhi: Alembic Pharma group firm Rhizen Pharmaceuticals SA has entered into an exclusive worldwide license agreement with Novartis for the...
Cipla to transfer consumer healthcare business to subsidiary savita thakur thakur11 Dec 2015 11:39 AM ISTNEW DELHI: Drug major Cipla today said its board has approved the transfer of its consumer healthcare business to a wholly-owned subsidiary--Cipla...
Pharma committee to be constituted by the centre Pooja Bhatia Bhatia14 Oct 2015 10:43 AM ISTAn inter ministerial coordination committee under the supervision of the central govt will soon be formed to closely monitor the growth of the 2 Lakh...
